サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1621146

実験動物モデル・3D培養・オルガノイド：世界市場

Laboratory Animal Models, 3D Cultures, and Organoids: Global Markets
PrevNext
1
2
3
4

出版日
発行
BCC Research
ページ情報
英文 130 Pages
納期
即納可能 即納可能とは
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.06円
実験動物モデル・3D培養・オルガノイド：世界市場
出版日: 2024年12月17日
発行: BCC Research
ページ情報: 英文 130 Pages
納期: 即納可能 即納可能とは
PrevNext
1
2
3
4
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の実験動物モデル・3D培養・オルガノイドの市場規模は、2024年の28億米ドルから、予測期間中はCAGR 12.5％で推移し、2029年には50億米ドルに達すると予測されています。

動物モデルの部門は、2024年の18億米ドルから、予測期間中はCAGR 12.2%で推移し、2029年には32億米ドルに達すると予測されています。3D細胞培養の部門は、2024年の10億米ドルから、CAGR 13.2%で推移し、2029年には19億米ドルに達すると予測されます。

当レポートでは、世界の実験動物モデル・3D培養・オルガノイドの市場を調査し、市場概要、市場影響因子および市場機会の分析、法規制環境、新興技術および技術開発の動向、市場規模の推移・予測、各種区分・地域別の詳細分析、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 エグゼクティブサマリー

  • 市場見通し
  • 調査範囲
  • 市場分析

第2章 市場概要

  • 概要
  • ポーターのファイブフォース分析

第3章 市場力学

  • 概要
  • 市場促進要因
  • 動物実験の倫理的代替法への注目
  • 腫瘍モデリングとバイオバンキングの需要増加
  • オルガノイド技術の幅広い用途への採用拡大
  • 市場抑制要因
  • 細胞培養と幹細胞の研究開発を規制する厳格な政府規制
  • オルガノイドを既存の調査手法に組み込む際の課題
  • 市場機会
  • 医薬品開発、個別化医療、移植への応用

第4章 規制状況

  • 規制シナリオ
  • 米国
  • 欧州連合
  • 英国
  • ドイツ
  • インド

第5章 新興技術

  • 概要
  • 3Dプリント
  • マイクロ流体
  • AIと自動化
  • 特許分析

第6章 市場セグメンテーション分析

  • セグメンテーションの内訳
  • 世界の実験動物モデル・3D培養・オルガノイド市場：動物モデル別
  • 動物モデル
  • 世界の市場規模と予測
  • マウス
  • ネズミ
  • ウサギ
  • ハムスター
  • モルモット
  • その他
  • 世界の実験動物モデル・3D培養・オルガノイド市場：3D培養別
  • 3D培養
  • 世界の市場規模と予測
  • 臓器オンチップ
  • オルガノイド
  • 腸
  • 肝臓
  • 胃
  • 膵臓
  • 肺
  • 腎臓
  • その他
  • スフェロイド
  • 世界の実験動物モデル・3D培養・オルガノイド市場：用途別
  • 発生生物学
  • 創薬と個別化医療
  • 再生医療
  • 感染症の病理学
  • 薬物の毒性と有効性の試験
  • その他
  • 地理的内訳
  • 世界の実験動物モデル・3D培養・オルガノイド市場：地域別
  • 世界の市場規模と予測
  • 北米
  • 米国
  • カナダ
  • 市場規模と予測
  • 欧州
  • ドイツ
  • 英国
  • 市場規模と予測
  • アジア太平洋
  • その他の地域

第7章 競合情報

  • 競合情勢
  • 戦略分析

第8章 実験動物モデル・3D培養・オルガノイドにおける持続可能性：ESGの観点

  • ESG：イントロダクション
  • 市場における持続可能性
  • ESGの視点
  • 環境への影響
  • 社会的影響
  • ガバナンス

第9章 付録

  • 調査手法
  • 略語
  • 出典
  • 企業プロファイル
  • 3D BIOTEK LLC.
  • BIO-TECHNE
  • CELLINK
  • CHARLES RIVER LABORATORIES
  • CHERRY BIOTECH
  • CORNING INC.
  • EMULATE
  • GENOWAY
  • GREINER BIO-ONE INTERNATIONAL GMBH
  • INSPHERO
  • MATTEK
  • MIMETAS B.V.
  • PEPGEL LLC.
  • POIETIS
  • TACONIC BIOSCIENCES INC.
  • THEWELL BIOSCIENCE INC.
  • THERMO FISHER SCIENTIFIC INC.
図表

List of Tables

  • Summary Table : Global Market for Laboratory Animal Models, 3D Cultures, and Organoids, by Segment, Through 2029
  • Table 1 : Animal Model vs. 3D Cell Culture
  • Table 2 : Porter's Five Forces Analysis: Laboratory Animal Models, 3D Cultures, and Organoids
  • Table 3 : Patent Analysis for 3D Cell Culture
  • Table 4 : Global Market for Animal Models, by Animal Type, Through 2029
  • Table 5 : Global Market for Mice Animal Models, by Region, Through 2029
  • Table 6 : Global Market for Rat Animal Models, by Region, Through 2029
  • Table 7 : Global Market for Rabbit Animal Models, by Region, Through 2029
  • Table 8 : Global Market for Hamster Animal Models, by Region, Through 2029
  • Table 9 : Global Market for Guinea Pig Animal Models, by Region, Through 2029
  • Table 10 : Global Market for Other Animal Models, by Region, Through 2029
  • Table 11 : Global Market for 3D Cell Cultures, by 3D Type, Through 2029
  • Table 12 : Global Market for Organ-on-chips in 3D Cultures, by Region, Through 2029
  • Table 13 : Global Market for Organoids in 3D Cultures, by Organ Type, Through 2029
  • Table 14 : Global Market for Organoid in 3D Cultures, by Region, Through 2029
  • Table 15 : Global Market for Intestines in Organoids, by Region, Through 2029
  • Table 16 : Global Market for Livers in Organoids, by Region, Through 2029
  • Table 17 : Global Market for Stomachs in Organoids, by Region, Through 2029
  • Table 18 : Global Market for Pancreases in Organoids, by Region, Through 2029
  • Table 19 : Global Market for Lungs in Organoids, by Region, Through 2029
  • Table 20 : Global Market for Kidneys in Organoids, by Region, Through 2029
  • Table 21 : Global Market for Other in Organoids, by Region, Through 2029
  • Table 22 : Global Market for Spheroids in 3D Cultures, by Region, Through 2029
  • Table 23 : Global Market for Laboratory Animal Models, 3D Cultures, and Organoids, by Application, Through 2029
  • Table 24 : Global Market for Developmental Biology in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
  • Table 25 : Global Market for Drug Discovery and Personalized Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
  • Table 26 : Global Market for Regenerative Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
  • Table 27 : Global Market for Pathology of Infectious Diseases in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
  • Table 28 : Global Market for Drug Toxicity and Efficacy Testing in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
  • Table 29 : Global Market for Other Applications in Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
  • Table 30 : Global Market for Laboratory Animal Models, 3D Cultures and Organoids, by Region, Through 2029
  • Table 31 : North American Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
  • Table 32 : North American Market for 3D Cell Cultures, by Type, Through 2029
  • Table 33 : North American Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
  • Table 34 : European Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
  • Table 35 : European Market for 3D Cell Cultures, by Type, Through 2029
  • Table 36 : European Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
  • Table 37 : Asia-Pacific Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
  • Table 38 : Asia-Pacific Market for 3D Cell Cultures, by Type, Through 2029
  • Table 39 : Asia-Pacific Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
  • Table 40 : Rest of the World Market for Laboratory Animal Models, 3D Cultures and Organoids, by Segment, Through 2029
  • Table 41 : Rest of the World Market for 3D Cell Cultures, by Type, Through 2029
  • Table 42 : Rest of the World Market for Laboratory Animal Models, 3D Cultures and Organoids, by Applications, Through 2029
  • Table 43 : Global Company Rankings in the Market for Laboratory Animal Models, 3D Cultures and Organoids, 2023
  • Table 44 : Key ESG Metrics Focus Areas
  • Table 45 : ESG Rankings for CRO Services, 2023
  • Table 46 : Abbreviations Used in this Report
  • Table 47 : Report Sources
  • Table 48 : 3D Biotek LLC.: Company Snapshot
  • Table 49 : 3D Biotek LLC.: Product Portfolio
  • Table 50 : Bio-Techne: Company Snapshot
  • Table 51 : Bio-Techne: Financial Performance, FY 2022 and 2023
  • Table 52 : Bio-Techne: Product Portfolio
  • Table 53 : Bio-Techne: News/Key Developments, 2022
  • Table 54 : Cellink: Company Snapshot
  • Table 55 : Cellink: Product Portfolio
  • Table 56 : Cellink: News/Key Developments, 2023
  • Table 57 : Charles River Laboratories: Company Snapshot
  • Table 58 : Charles River Laboratories: Financial Performance, FY 2022 and 2023
  • Table 59 : Charles River Laboratories: Products Portfolio
  • Table 60 : Charles River Laboratories: News/Key Developments, 2023
  • Table 61 : Cherry Biotech: Company Snapshot
  • Table 62 : Cherry Biotech: Product Portfolio
  • Table 63 : Corning Inc.: Company Snapshot
  • Table 64 : Corning Inc.: Financial Performance, FY 2022 and 2023
  • Table 65 : Corning Inc.: Product Portfolio
  • Table 66 : Corning Inc.: News/Key Developments, 2022-2024
  • Table 67 : Emulate: Company Snapshot
  • Table 68 : Emulate: Product Portfolio
  • Table 69 : Emulate: News/Key Developments, 2021-2023
  • Table 70 : genOway: Company Snapshot
  • Table 71 : genOway: Financial Performance, FY 2022 and 2023
  • Table 72 : genOway: Product Portfolio
  • Table 73 : genOway: News/Key Developments, 2021 and 2022
  • Table 74 : Greiner Bio-One International GmbH: Company Snapshot
  • Table 75 : Greiner Bio-One International GmbH: Product Portfolio
  • Table 76 : InSphero: Company Snapshot
  • Table 77 : InSphero: Product Portfolio
  • Table 78 : InSphero: News/Key Developments, 2023
  • Table 79 : MatTek: Company Snapshot
  • Table 80 : MatTek: Product Portfolio
  • Table 81 : Mimetas B.V.: Company Snapshot
  • Table 82 : Mimetas B.V.: Product Portfolio
  • Table 83 : Mimetas B.V.: News/Key Developments, 2023-2024
  • Table 84 : PepGel LLC.: Company Snapshot
  • Table 85 : PepGel LLC.: Product Portfolio
  • Table 86 : Poietis: Company Snapshot
  • Table 87 : Poietis: Product Portfolio
  • Table 88 : Poietis: News/Key Developments, 2024
  • Table 89 : Taconic Biosciences Inc.: Company Snapshot
  • Table 90 : Taconic Biosciences Inc.: Product Portfolio
  • Table 91 : TheWell Bioscience Inc.: Company Snapshot
  • Table 92 : TheWell Bioscience Inc.: Product Portfolio
  • Table 93 : TheWell Bioscience Inc.: News/Key Developments, 2023-2024
  • Table 94 : Thermo Fisher Scientific Inc.: Company Snapshot
  • Table 95 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2022 and 2023
  • Table 96 : Thermo Fisher Scientific Inc.: Product Portfolio

List of Figures

  • Summary Figure : Global Market Shares of Laboratory Animal Models, 3D Cultures, and Organoids, by Segment, 2021-2029
  • Figure 1 : Animal Modelling for Drug Discovery
  • Figure 2 : Evolution of 3D Cell Culture
  • Figure 3 : Market Dynamics of Laboratory Animal Models, 3D Cultures, and Organoids
  • Figure 4 : Global Market Shares of Animal Models, by Animal Type, 2023
  • Figure 5 : Global Market Shares of Mice Animal Models, by Region, 2023
  • Figure 6 : Global Market Shares of Rat Animal Models, by Region, 2023
  • Figure 7 : Global Market Shares of Rabbit Animal Models, by Region, 2023
  • Figure 8 : Global Market Shares of Hamster Animal Models, by Region, 2023
  • Figure 9 : Global Market Shares of Guinea Pig Animal Models, by Region, 2023
  • Figure 10 : Global Market Shares of Other Animal Models, by Region, 2023
  • Figure 11 : Types of 3D Cell Culture Utilized in Drug Discovery
  • Figure 12 : Global Market Shares of 3D Cell Cultures, by 3D Type, 2023
  • Figure 13 : Global Market Shares of Organ-on-chips in 3D Cultures, by Region, 2023
  • Figure 14 : Global Market Shares of Organoids in 3D Cultures, by Organ Type, 2023
  • Figure 15 : Global Market Shares of Organoid in 3D Cultures, by Region, 2023
  • Figure 16 : Global Market Shares of Intestines in Organoids, by Region, 2023
  • Figure 17 : Global Market Shares of Livers in Organoids, by Region, 2023
  • Figure 18 : Global Market Shares of Livers in Organoids, by Region, 2023
  • Figure 19 : Global Market Shares of Pancreases in Organoids, by Region, 2023
  • Figure 20 : Global Market Shares of Lungs in Organoids, by Region, 2023
  • Figure 21 : Global Market Shares of Kidneys in Organoids, by Region, 2023
  • Figure 22 : Global Market Shares of Other in Organoids, by Region, 2023
  • Figure 23 : Global Market Shares of Spheroids in 3D Cultures, by Region, 2023
  • Figure 24 : Global Market Shares of Laboratory Animal Models, 3D Cultures, and Organoids, by Application, 2023
  • Figure 25 : Global Market Shares of Developmental Biology in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
  • Figure 26 : Global Market Shares of Drug Discovery and Personalized Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
  • Figure 27 : Global Market Shares of Regenerative Medicine in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
  • Figure 28 : Global Market Shares of Pathology of Infectious Diseases in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
  • Figure 29 : Global Market Shares of Drug Toxicity and Efficacy Testing in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
  • Figure 30 : Global Market Shares of Other Applications in Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
  • Figure 31 : Global Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
  • Figure 32 : North American Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023
  • Figure 33 : North American Market Shares of 3D Cell Cultures, by Type, 2023
  • Figure 34 : North American Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023
  • Figure 35 : European Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segmen, 2023
  • Figure 36 : European Market Shares of 3D Cell Cultures, by Type, 2023
  • Figure 37 : European Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023
  • Figure 38 : Asia-Pacific Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023
  • Figure 39 : Asia-Pacific Market Shares of 3D Cell Cultures, by Type, 2023
  • Figure 40 : Asia-Pacific Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Country, 2023
  • Figure 41 : Rest of the World Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Segment, 2023
  • Figure 42 : Rest of the World Market Shares of 3D Cell Cultures, by Type, 2023
  • Figure 43 : Rest of the World Market Shares of Laboratory Animal Models, 3D Cultures and Organoids, by Region, 2023
  • Figure 44 : Pillars of ESG
  • Figure 45 : Advantages of ESG for Companies
  • Figure 46 : Bio-Techne: Revenue Shares, by Segment, 2023
  • Figure 47 : Bio-Techne: Revenue Shares, by Country/Region, 2023
  • Figure 48 : Charles River Laboratories: Revenue Shares, by Business Unit, FY 2023
  • Figure 49 : Charles River Laboratories: Revenue Shares, by Country/Region, FY 2023
  • Figure 50 : Corning Inc.: Revenue Shares, by Business Unit, FY 2023
  • Figure 51 : Corning Inc.: Revenue Shares, by Country/Region, FY 2023
  • Figure 52 : Thermo Fisher Scientific Inc.: Revenue Shares, by Business Unit, FY 2023
  • Figure 53 : Thermo Fisher Scientific Inc.: Revenue Shares, by Country/Region, FY 2023
目次
Product Code: PHM204C

The global market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $2.8 billion in 2024 to reach $5.0 billion by 2029, at a compound annual growth rate (CAGR) of 12.5% from 2024 through 2029.

The animal model market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $1.8 billion in 2024 to reach $3.2 billion by 2029, at a CAGR of 12.2% from 2024 through 2029.

The 3D cell culture market for laboratory animal models, 3D cultures, and organoids is estimated to increase from $1.0 billion in 2024 to reach $1.9 billion by 2029, at a CAGR of 13.2% from 2024 through 2029.

Report Scope

The global laboratory animal models, 3D cultures, and organoids market is identified and explored in this report, as are all significant global companies active in the market. Markets are broken out globally and by geographic region. Additionally, all major animal models and applications are covered in detail. The current report will provide detailed exposure about this market.

This report analyzes market trends using data from 2023, estimates from 2024, projections of compound annual growth rates through 2029 (forecast period 2024-2029), and regional markets. This report will highlight current and future market potential and give a detailed analysis of the competitive environment. The report will cover regulatory scenarios, drivers, restraints, and opportunities. The report also covers market projections for 2029 and the market shares of key players.

This report details market shares for the different segments, their types and applications, end users, and geography. Based on animal models, the market is segmented into gelatin and vegetarian capsules. The market is segmented based on its nutritional, pharmaceutical, and cosmeceutical applications. Based on end users, the market is segmented into pharmaceutical and nutraceutical companies, contract manufacturing companies, and others.

The market has been segmented into significant geographies: North America, Europe, Asia-Pacific, and other world regions. The regional segment includes a detailed analysis of major countries such as the U.S., Germany, the U.K., France, Japan, China, and India.

The report's goals include:

  • Analyzing product types and applications.
  • Analyzing global market size and segmentation.
  • Understanding market constraints and drivers.
  • Providing detailed market forecasts up to 2029.
  • Assessing market shares, competitiveness, and industry structure.
  • Identifying potential long-term impacts on the market.

Report Includes

  • 45 data tables and 52 additional tables
  • An up-to-date review and analysis of the global markets for the laboratory animal models, 3D cell cultures, and organoids within the industry
  • Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
  • Estimation of the actual market size and market forecast for organoids, and their corresponding market share analysis by product type, application, and geographic region
  • Coverage of the current state of the industry structure, novel technological updates and issues surrounding integration of organoids and stringent regulatory constraints, ongoing research activities, and COVID-19 impact on the overall market
  • Information on the current trends that significantly affect the basic research, biomedical and other industries where animals are used for toxicity testing and for evaluating the safety and metabolism of chemical compounds
  • Analysis of market opportunities with a holistic review of advantages and disadvantages of the 3D cell cultures, animal models, and organoids in the prevailing biopharmaceuticals industry
  • Review of selected patents and patent applications on organoids, and emerging developments in the global market
  • Identification of the major stakeholders and analysis of the competitive landscape based on recent developments and segmental revenues
  • Assessment of mergers and acquisitions, joint ventures, partnerships, and other market strategies
  • A discussion of ESG challenges and practices in the industry
  • Company profiles of major players within the industry, including Thermo Fisher Scientific Inc., Corning Inc., genOway, Charles River Laboratories, and Bio-Techne.

Table of Contents

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Overview
  • Porter's Five Forces Analysis
  • Bargaining Power of Buyers
  • Bargaining Power of Suppliers
  • Potential for New Entrants
  • Threat of Substitutes
  • Competitiveness in the Industry

Chapter 3 Market Dynamics

  • Overview
  • Market Drivers
  • Growing Focus on Ethical Alternatives to Animal Testing
  • Increasing Demand for Tumor Modeling and Biobanking Fuel Market Expansion
  • Increasing Adoption of Organoid Technology for Wider Applications
  • Market Restraints
  • Strict Government Regulations Governing Cell Cultures and Stem Cells R&D
  • Challenges in Incorporating Organoids into Existing Research Practices
  • Market Opportunities
  • Applications in Drug Development, Personalized Medicine, and Transplantation

Chapter 4 Regulatory Landscape

  • Regulatory Scenarios
  • United States
  • EU
  • U.K.
  • Germany
  • India

Chapter 5 Emerging Technologies

  • Overview
  • 3D Printing
  • Microfluidics
  • Artificial Intelligence and Automation
  • Patent Analysis

Chapter 6 Market Segmentation Analysis

  • Segmentation Breakdown
  • Global Market for Laboratory Animal Models, 3D Cultures and Organoids, by Animal Model
  • Animal Models
  • Global Market Size and Forecast
  • Mice
  • Rats
  • Rabbits
  • Hamsters
  • Guinea Pigs
  • Others
  • Global Market for Laboratory Animal Models, 3D Cultures and Organoid, by 3D Cultures
  • 3D Cultures
  • Global Market Size and Forecast
  • Organ-on-chip
  • Organoids
  • Intestine
  • Liver
  • Stomach
  • Pancreas
  • Lung
  • Kidney
  • Others
  • Spheroids
  • Global Market for Laboratory Animal Models, 3D Cultures and Organoids by Application
  • Developmental Biology
  • Drug Discovery and Personalized Medicine
  • Regenerative Medicine
  • Pathology of Infectious Disease
  • Drug Toxicity and Efficacy Testing
  • Others
  • Geographic Breakdown
  • Global Market for Laboratory Animal Models, 3D Cultures and Organoids by Region
  • Global Market Size and Forecast
  • North America
  • U.S.
  • Canada
  • Market Size and Forecast
  • Europe
  • Germany
  • U.K.
  • Market Size and Forecast
  • Asia-Pacific
  • Rest of the World

Chapter 7 Competitive Intelligence

  • Competitive Landscape
  • Strategic Analysis

Chapter 8 Sustainability in Laboratory Animal Models, 3D Cultures, and Organoids: An ESG Perspective

  • Introduction to ESG
  • Sustainability in the Market
  • ESG Perspective
  • Environmental Impact
  • Social Impact
  • Governance

Chapter 9 Appendix

  • Methodology
  • Abbreviations
  • Sources
  • Company Profiles
  • 3D BIOTEK LLC.
  • BIO-TECHNE
  • CELLINK
  • CHARLES RIVER LABORATORIES
  • CHERRY BIOTECH
  • CORNING INC.
  • EMULATE
  • GENOWAY
  • GREINER BIO-ONE INTERNATIONAL GMBH
  • INSPHERO
  • MATTEK
  • MIMETAS B.V.
  • PEPGEL LLC.
  • POIETIS
  • TACONIC BIOSCIENCES INC.
  • THEWELL BIOSCIENCE INC.
  • THERMO FISHER SCIENTIFIC INC.